These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 12658930

  • 1. [Effects of trimetazidine on serum oxygen free radicals in congestive heart failure].
    Ma QL, Xie Y, Zhang SD.
    Hunan Yi Ke Da Xue Xue Bao; 2002 Dec 28; 27(6):527-9. PubMed ID: 12658930
    [Abstract] [Full Text] [Related]

  • 2. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
    Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, Calori G, Alfieri O, Margonato A.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):992-8. PubMed ID: 16949492
    [Abstract] [Full Text] [Related]

  • 3. [Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
    Fedorova TA, Il'ina IuV, Sotnikova TI, Rybakova MK.
    Klin Med (Mosk); 2004 Sep 05; 82(11):15-20. PubMed ID: 15656392
    [Abstract] [Full Text] [Related]

  • 4. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
    Fragasso G, Perseghin G, De Cobelli F, Esposito A, Palloshi A, Lattuada G, Scifo P, Calori G, Del Maschio A, Margonato A.
    Eur Heart J; 2006 Apr 05; 27(8):942-8. PubMed ID: 16510466
    [Abstract] [Full Text] [Related]

  • 5. Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effect.
    Belardinelli R, Solenghi M, Volpe L, Purcaro A.
    Eur Heart J; 2007 May 05; 28(9):1102-8. PubMed ID: 17456483
    [Abstract] [Full Text] [Related]

  • 6. [Clinical and hemodynamic efficacy of selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease].
    Fedorova TA, Il'ina IuV, Sotnikova TI, Rybakova MK, Loshchits NV.
    Ter Arkh; 2004 May 05; 76(3):62-8. PubMed ID: 15108463
    [Abstract] [Full Text] [Related]

  • 7. Trimetazidine inhibits cardiomyocyte apoptosis in a rabbit model of ischemia-reperfusion.
    Ruixing Y, Wenwu L, Al-Ghazali R.
    Transl Res; 2007 Mar 05; 149(3):152-60. PubMed ID: 17320801
    [Abstract] [Full Text] [Related]

  • 8. Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure.
    Fragasso G, Salerno A, Lattuada G, Cuko A, Calori G, Scollo A, Ragogna F, Arioli F, Bassanelli G, Spoladore R, Luzi L, Margonato A, Perseghin G.
    Heart; 2011 Sep 05; 97(18):1495-500. PubMed ID: 21700755
    [Abstract] [Full Text] [Related]

  • 9. Trimetazidine shortens QTc interval in patients with ischemic heart failure.
    Zemljic G, Bunc M, Vrtovec B.
    J Cardiovasc Pharmacol Ther; 2010 Mar 05; 15(1):31-6. PubMed ID: 19966175
    [Abstract] [Full Text] [Related]

  • 10. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
    Vitale C, Wajngaten M, Sposato B, Gebara O, Rossini P, Fini M, Volterrani M, Rosano GM.
    Eur Heart J; 2004 Oct 05; 25(20):1814-21. PubMed ID: 15474696
    [Abstract] [Full Text] [Related]

  • 11. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R, Lacalaprice F, Faccenda E, Volpe L.
    Eur J Cardiovasc Prev Rehabil; 2008 Oct 05; 15(5):533-40. PubMed ID: 18797405
    [Abstract] [Full Text] [Related]

  • 12. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
    Belardinelli R, Cianci G, Gigli M, Mazzanti M, Lacalaprice F.
    J Cardiovasc Pharmacol; 2008 Jun 05; 51(6):611-5. PubMed ID: 18574390
    [Abstract] [Full Text] [Related]

  • 13. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
    Cioffi G, Tarantini L, Stefenelli C, Azzetti G, Marco R, Carlucci S, Furlanello F.
    J Card Fail; 2006 Oct 05; 12(8):608-15. PubMed ID: 17045179
    [Abstract] [Full Text] [Related]

  • 14. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
    Di Napoli P, Di Giovanni P, Gaeta MA, Taccardi AA, Barsotti A.
    J Cardiovasc Pharmacol; 2007 Nov 05; 50(5):585-9. PubMed ID: 18030070
    [Abstract] [Full Text] [Related]

  • 15. Protective effects of hydroxysafflor yellow A on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS and oxidative stress in rats.
    He H, Yang X, Shi M, Zeng X, Yang J, Wu L, Li L.
    J Pharm Pharmacol; 2008 Jan 05; 60(1):115-23. PubMed ID: 18088512
    [Abstract] [Full Text] [Related]

  • 16. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S.
    Am Heart J; 2003 Mar 05; 145(3):459-66. PubMed ID: 12660669
    [Abstract] [Full Text] [Related]

  • 17. Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis.
    Zhang L, Lu Y, Jiang H, Zhang L, Sun A, Zou Y, Ge J.
    J Am Coll Cardiol; 2012 Mar 06; 59(10):913-22. PubMed ID: 22381427
    [Abstract] [Full Text] [Related]

  • 18. Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.
    Yamada T, Node K, Mine T, Morita T, Kioka H, Tsukamoto Y, Tamaki S, Masuda M, Okuda K, Fukunami M.
    Am Heart J; 2007 Jun 06; 153(6):1055.e1-8. PubMed ID: 17540209
    [Abstract] [Full Text] [Related]

  • 19. [Effect of puerarin on heart function and serum oxidized-LDL in the patients with chronic cardiac failure].
    Duan S, Li YF, Luo XL.
    Hunan Yi Ke Da Xue Xue Bao; 2000 Apr 28; 25(2):176-8. PubMed ID: 12212215
    [Abstract] [Full Text] [Related]

  • 20. [Effects of Trimetazidine upon ventricular remodeling and GLUT4 in diabetic rats after myocardial infarction].
    Zhang RY, Yu P, Wang F, Shen JX, Wang YM.
    Zhonghua Yi Xue Za Zhi; 2009 May 12; 89(18):1240-5. PubMed ID: 19595176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.